Alpha 2.0
Login Register
» Authors » Takafumi Machimoto

Takafumi Machimoto

Explore the profile of Takafumi Machimoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 348
Followers 0
Related Specialties
Gastroenterology
General Surgery
Oncology
Top 10 Co-Authors
Yoshio Kadokawa
Tsunehiro Yoshimura
Shigeru Kato
Yuki Aisu
Shinji Uemoto
Daiki Yasukawa
Yusuke Kimura
Toshiyuki Hata
Iwao Ikai
Tomohide Hori
Published In
Gan To Kagaku Ryoho
Am J Case Rep
World J Gastroenterol
Anticancer Res
Ann Gastroenterol
Affiliations
Soon will be listed here.
Recent Articles
1.
[A Case of Hepatocellular Carcinoma with Simultaneous Bone Metastasis Successfully Treated with Multidisciplinary Therapy]
Goto T, Sawada S, Ishida K, Ko R, Iwasaki Y, Nakanishi N, et al.
Gan To Kagaku Ryoho . 2024 Dec; 51(12):1243-1245. PMID: 39721786
The patient was a 52-year-old male, who, after experiencing lower back pain, underwent further investigation and was diagnosed with hepatocellular carcinoma with sacral metastasis. The hepatocellular carcinoma was a 9...
2.
Refractory Chylous Ascites Leading to Chylothorax Following Extended Right Hepatectomy for Intrahepatic Cholangiocarcinoma
Morino K, Morimura Y, Tanaka H, Machimoto T, Nakagawa T
Cureus . 2024 Dec; 16(11):e73301. PMID: 39655122
Chylous ascites, a rare but severe complication of abdominal surgery, often results from lymphatic vessel damage during procedures, such as extended resection and lymphadenectomy. Although conservative management through dietary modifications...
3.
Delayed-Onset Immune-Related Colitis Following Pancreaticoduodenectomy in Patients With Gastric Cancer and Pancreatic Invasion Treated With Immune Checkpoint Inhibitors
Morino K, Nagatomo S, Ishida K, Ueo T, Machimoto T
Cureus . 2024 Oct; 16(9):e68480. PMID: 39360120
Immune checkpoint inhibitors (ICIs) have been approved for treating various advanced malignancies. Immune-related adverse events (irAEs) can manifest diversely and at varying times. However, postoperative diarrhea is a common complication...
4.
Clinical Implications and Risk Factors of Dilatation of Remnant Pancreatic Duct at 1 Year after Pancreatoduodenectomy: A Prospective, Japanese, Multicenter, Observational Cohort Study (DAIMONJI Study)
Narita M, Hatano E, Kitamura K, Terajima H, Kitagawa H, Mitsuoka E, et al.
J Am Coll Surg . 2024 May; 239(5):471-484. PMID: 38813957
Background: To determine the precise frequency of main pancreatic duct (MPD) dilatation within the remnant pancreas at 1 year after pancreatoduodenectomy (PD) and its clinical implications, a prospective multicenter cohort...
5.
Esophagogastrostomy Double Tract Reconstruction for Laparoscopic Proximal Gastrectomy: Short-term Outcomes Based on Nutritional Parameters and Skeletal Muscle Index
Morino K, Kitano T, Kadokawa Y, Nakanishi N, Yamamoto M, Machimoto T
In Vivo . 2024 Apr; 38(3):1325-1331. PMID: 38688630
Background/aim: The optimal reconstruction method for laparoscopic proximal gastrectomy (LPG) remains controversial. The present study aimed to compare short-term outcomes, including assessment of nutritional parameters and skeletal muscle, between two...
6.
Safety and Limitations of Laparoscopic Total Gastrectomy for Gastric Cancer: A Comparative Analysis of Short and Long-term Outcomes With Open Surgery
Morino K, Yamamoto M, Shimoike N, Iwasaki Y, Yamanaka R, Nakanishi N, et al.
Anticancer Res . 2024 Mar; 44(4):1759-1766. PMID: 38537974
Background/aim: Laparoscopic gastrectomy is a standard treatment strategy for gastric cancer (GC); however, the clinical impact of laparoscopic total gastrectomy (LTG) on survival outcomes remains unclear. We compared the short-...
7.
Proposal of the novel predictive model for postoperative pancreatic fistula in distal pancreatectomy for pancreatic tumor based on preoperative imaging parameters and stapler handling
Morino K, Nakano K, Goto T, Tanaka H, Machimoto T
World J Surg . 2024 Feb; 48(4):932-942. PMID: 38375966
Background: Distal pancreatectomy (DP) using linear staplers is widely performed; however, postoperative pancreatic fistulas (POPF) remain an issue. This study aimed to analyze preoperative risk factors for POPF and assess...
8.
Management of Patients Receiving Antiplatelet Therapy During Gastroenterological Surgery: A Multicenter Prospective Cohort Study (GSATT)
Fujikawa T, Hasegawa S, Takahashi R, Naito S, Kaihara S, Uryuhara K, et al.
Ann Surg . 2023 Oct; 280(1):82-90. PMID: 37870247
Objective: This study aimed to evaluate the effect of continuing preoperative aspirin monotherapy on surgical outcomes in patients receiving antiplatelet therapy (APT). Background: The effectiveness of continuing preoperative aspirin monotherapy...
9.
Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant Chemotherapy
Morino K, Yamamoto M, Yamanaka R, Iwasaki Y, Nakanishi N, Goto T, et al.
Anticancer Res . 2023 Apr; 43(5):2203-2209. PMID: 37097653
Background/aim: The impact of laparoscopic gastrectomy (LG), a standard gastric cancer (GC) management strategy, in advanced GC cases involving doublet adjuvant chemotherapy remains unclear. This study was aimed at comparing...
10.
Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis
Yamamoto T, Kawada K, Matsusue R, Kato S, Itatani Y, Hida K, et al.
Int J Colorectal Dis . 2022 Sep; 37(10):2207-2218. PMID: 36156129
Purpose: For rectal cancer, a multimodality approach is mandatory including neoadjuvant chemoradiotherapy, neoadjuvant chemotherapy, and lateral pelvic lymph node (LPLN) dissection, in addition to the total mesorectal excision (TME). However,...